#medtechinnovator — Public Fediverse posts

Hey, I'm Birk, Co-founder of #CYMANTICMEDICAL an #Irish #Medtech #startup addressing the issue of inadequate sampling during #cancer #biopsies.

We are taking part in the #medtechinnovator #accelerator in #sanfrancisco the world's biggest medtech accelerator. Part of it is a video competition and our video is now online and we need YOU to WATCH, VOTE and SHARE!

About 25% of cancer biopsies are inadequate for a diagnosis and 30% of cancer surgeries are incomplete - meaning they require a repeat procedure weeks after the the first.

This takes a toll on the patients, delays diagnosis and treatment and drives up the cost by 40% to 80% and reducing the hospital throughput while the timing for the patients would be critical.

We address this via automated sample preparation and computer vision to get real time results directly in the procedure room.

Please , watch our video, vote and share:

https://medtechinnovator.org/company-videos-2026/?record=65702

#cancer #surgery #biopsy #startup #Dublin #medtechinnovator #MTI #BRYCK #UCD #neurodivergent #oncology 🖖🤓🤘

www.cymanticmedical.com

Hey, I'm Birk, Co-founder of #CYMANTICMEDICAL an #Irish #Medtech #startup addressing the issue of inadequate sampling during #cancer #biopsies.

We are taking part in the #medtechinnovator #accelerator in #sanfrancisco the world's biggest medtech accelerator. Part of it is a video competition and our video is now online and we need YOU to WATCH, VOTE and SHARE!

About 25% of cancer biopsies are inadequate for a diagnosis and 30% of cancer surgeries are incomplete - meaning they require a repeat procedure weeks after the first.

This takes a toll on the patients, delays diagnosis and treatment and drives up the cost by 40% to 80% and reducing the hospital throughput while the timing for the patients would be critical.

We address this via automated sample preparation and computer vision to get real time results directly in the procedure room.

Please , watch our video, vote and share:

https://medtechinnovator.org/company-videos-2026/?record=65702

#cancer #surgery #biopsy #startup #Dublin #medtechinnovator #MTI #BRYCK #UCD #neurodivergent #oncology 🖖🤓🤘
#computervision

www.cymanticmedical.com

Hey, I'm Birk, Co-founder of #CYMANTICMEDICAL an #Irish #Medtech #startup addressing the issue of inadequate sampling during #cancer #biopsies.

We are taking part in the #medtechinnovator #accelerator in #sanfrancisco the world's biggest medtech accelerator. Part of it is a video competition and our video is now online and we need YOU to WATCH, VOTE and SHARE!

About 25% of cancer biopsies are inadequate for a diagnosis and 30% of cancer surgeries are incomplete - meaning they require a repeat procedure weeks after the first.

This takes a toll on the patients, delays diagnosis and treatment and drives up the cost by 40% to 80% and reducing the hospital throughput while the timing for the patients would be critical.

We address this via automated sample preparation and computer vision to get real time results directly in the procedure room.

Please , watch our video, vote and share:

https://medtechinnovator.org/company-videos-2026/?record=65702

#cancer #surgery #biopsy #startup #Dublin #medtechinnovator #MTI #BRYCK #UCD #neurodivergent #oncology 🖖🤓🤘
#computervision

www.cymanticmedical.com

Hey, I'm Birk, Co-founder of #CYMANTICMEDICAL an #Irish #Medtech #startup addressing the issue of inadequate sampling during #cancer #biopsies.

We are taking part in the #medtechinnovator #accelerator in #sanfrancisco the world's biggest medtech accelerator. Part of it is a video competition and our video is now online and we need YOU to WATCH, VOTE and SHARE!

About 25% of cancer biopsies are inadequate for a diagnosis and 30% of cancer surgeries are incomplete - meaning they require a repeat procedure weeks after the first.

This takes a toll on the patients, delays diagnosis and treatment and drives up the cost by 40% to 80% and reducing the hospital throughput while the timing for the patients would be critical.

We address this via automated sample preparation and computer vision to get real time results directly in the procedure room.

Please , watch our video, vote and share:

https://medtechinnovator.org/company-videos-2026/?record=65702

#cancer #surgery #biopsy #startup #Dublin #medtechinnovator #MTI #BRYCK #UCD #neurodivergent #oncology 🖖🤓🤘
#computervision

www.cymanticmedical.com

Hey, I'm Birk, Co-founder of #CYMANTICMEDICAL an #Irish #Medtech #startup addressing the issue of inadequate sampling during #cancer #biopsies.

We are taking part in the #medtechinnovator #accelerator in #sanfrancisco the world's biggest medtech accelerator. Part of it is a video competition and our video is now online and we need YOU to WATCH, VOTE and SHARE!

About 25% of cancer biopsies are inadequate for a diagnosis and 30% of cancer surgeries are incomplete - meaning they require a repeat procedure weeks after the first.

This takes a toll on the patients, delays diagnosis and treatment and drives up the cost by 40% to 80% and reducing the hospital throughput while the timing for the patients would be critical.

We address this via automated sample preparation and computer vision to get real time results directly in the procedure room.

Please , watch our video, vote and share:

https://medtechinnovator.org/company-videos-2026/?record=65702

#cancer #surgery #biopsy #startup #Dublin #medtechinnovator #MTI #BRYCK #UCD #neurodivergent #oncology 🖖🤓🤘
#computervision

www.cymanticmedical.com